Overview
Douglas Reding is a Hematologist practicing medicine in Schofield, Wisconsin.
Dr. Reding is highly rated in 5 conditions, according to our data. His clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).
He is actively involved in clinical research, co-authoring 15 peer reviewed articles and participating in 2 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INDEMNITY
- POS
Locations
3301 Cranberry Blvd, Schofield, WI 54476
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
Aspirus Regional Cancer Center
Niaz Haque is a Hematologist and an Oncologist practicing medicine in Wausau, Wisconsin. Dr. Haque is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Cervical Cancer, and Bone Marrow Aspiration.
Aspirus Regional Cancer Center
Edward Mckenna is a Hematologist practicing medicine in Wausau, Wisconsin. He has been practicing medicine for over 10 years. Dr. Mckenna is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome.
Ascension Saint Mary?S Hospital
Harsha Poola is a Hematologist practicing medicine in Rhinelander, Wisconsin. Dr. Poola is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Thrombocytopenia, Familial Colorectal Cancer, Non-Small Cell Lung Cancer (NSCLC), and Large-Cell Lung Carcinoma.
Frequently Asked Questions about Dr. Douglas Reding
How do I make an appointment with Dr. Douglas Reding?
You can book an appointment with Dr. Douglas Reding by calling their office at 715-393-3886. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Douglas Reding a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Douglas Reding is classified as an Advanced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Douglas Reding specialize in?
While Dr. Douglas Reding is a Hematology, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, and Squamous Cell Lung Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Douglas Reding participate in research or clinical trials?
Yes. Dr. Douglas Reding has published 15 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Douglas Reding's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Douglas Reding accept my insurance?
Dr. Douglas Reding accepts most major insurance plans, including Anthem BCBS and Security Health. We recommend calling the office directly at 715-393-3886 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- ALK-Positive Non-Small Cell Lung Cancer
- Lung AdenocarcinomaDr. Reding isAdvanced. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Reding isAdvanced. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Reding isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Reding isAdvanced. Learn about Squamous Cell Lung Carcinoma.
- Experienced
- Acute Mountain SicknessDr. Reding isExperienced. Learn about Acute Mountain Sickness.
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Reding isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Reding isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Reding isExperienced. Learn about Agranulocytosis.